Suppr超能文献

性激素调节听觉脑干反应潜伏期。

Sex hormones regulate ABR latency.

作者信息

Elkind-Hirsch K E, Wallace E, Malinak L R, Jerger J J

机构信息

Department of Obstetrics/Gynecology, Baylor College of Medicine, Houston, TX.

出版信息

Otolaryngol Head Neck Surg. 1994 Jan;110(1):46-52. doi: 10.1177/019459989411000105.

Abstract

In an effort to characterize more completely the influence of sex hormones on auditory brainstem response (ABR) latency, we evaluated the ABRs of normal male and female subjects and women with previously diagnosed endocrinologic syndromes. We describe ABR latency results from the following subjects: five normal males, nine normally cycling females on no hormonal therapy, nine females using oral contraceptive pills, five females with premature ovarian failure (POF) undergoing cyclic estrogen-progesterone replacement therapy, and five hyperandrogenized females with polycystic ovarian disease (PCOD) treated with the gonadotropin-releasing hormone agonist, Lupron depot, to suppress ovarian steroid production. All subjects were between 23 and 40 years of age. Serum levels of estradiol, progesterone, testosterone, prolactic, and gonadotropins (lutienizing hormone and follicle stimulating hormone) were measured to document the hormonal status of each of the subjects at the time of the ABR evaluation. Normal cycling females and females with POF underwent ABR testing during different phases of the same cycle. Male subjects and females using birth control pills were studied four times in the same month at 1-week intervals. Females with PCOD were also studied four times; baseline and then at 2-week intervals after the initiation of Lupron depot therapy. Increased ABR wave V peak latencies were found to be associated with elevated levels of estrogen or testosterone. We have previously reported a lengthening of ABR wave V peak latencies coincident with peak estrogen levels during the female cycle.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

为了更全面地描述性激素对听觉脑干反应(ABR)潜伏期的影响,我们评估了正常男性和女性受试者以及先前诊断为内分泌综合征的女性的ABR。我们描述了以下受试者的ABR潜伏期结果:五名正常男性、九名未接受激素治疗的正常月经周期女性、九名使用口服避孕药的女性、五名接受周期性雌激素 - 孕激素替代治疗的卵巢早衰(POF)女性,以及五名患有多囊卵巢疾病(PCOD)的高雄激素女性,她们接受促性腺激素释放激素激动剂亮丙瑞林长效注射剂治疗以抑制卵巢类固醇生成。所有受试者年龄在23至40岁之间。测量了雌二醇、孕酮、睾酮、催乳素和促性腺激素(促黄体生成素和促卵泡生成素)的血清水平,以记录每个受试者在进行ABR评估时的激素状态。正常月经周期女性和POF女性在同一周期的不同阶段进行ABR测试。男性受试者和使用避孕药的女性在同一个月内每隔1周进行4次研究。患有PCOD的女性也进行了4次研究;基线水平,然后在开始亮丙瑞林长效注射剂治疗后每隔2周进行研究。发现ABR波V峰潜伏期增加与雌激素或睾酮水平升高有关。我们之前曾报道,在女性月经周期中,ABR波V峰潜伏期的延长与雌激素峰值一致。(摘要截短于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验